A/Prof Keith Lim
Clinical (Associate Professor)
Department of Medicine
50 Scholarly works
2 Projects
HIGHLIGHTS
2025
Journal article
Potential Significance of CCL17 in Psoriatic Arthritis
DOI: 10.1111/1756-185x.705262025
Journal article
Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain
DOI: 10.1038/s41598-025-12191-42024
Journal article
Regional ischaemic immune myopathy: unraveling a rare subtype of dermatomyopathy
DOI: 10.1136/bcr-2024-2608652024
Research grants (other domestic)
Biomarkers for Differentiating Spondyloarthritis and Osteoarthritis
2024
Journal article
The cardiovascular risk of JAK inhibitors in treating rheumatic diseases
DOI: 10.1111/1756-185X.153082024
Journal article
AB0213 THE CARDIOVASCULAR RISK OF JAK INHIBITORS IN TREATING RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2024-eular.21932021
Research Grant
Biomarkers for Differentiating Spondyloarthritis and Osteoarthritis
RECENT SCHOLARLY WORKS
2023
Journal article
Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis
DOI: 10.1016/j.isci.2023.1080792023
Journal article
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
DOI: 10.3389/fimmu.2023.11969312022
Journal article
Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
DOI: 10.1002/rai2.120422020
Conference Proceedings
HEALTH SERVICE USE AND RECOVERY OF QUALITY OF LIFE 12 MONTHS POST-FRACTURE: LATENT CLASS ANALYSES OF THE INTERNATIONAL COST AND UTILITIES RELATED TO OSTEOPOROTIC FRACTURES STUDY (ICUROS)
2020
Journal article
Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)
DOI: 10.1007/s10067-020-05356-1